These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36316998)

  • 21. The suitability of treating atopic dermatitis with Janus kinase inhibitors.
    Narla S; Silverberg JI
    Expert Rev Clin Immunol; 2022 May; 18(5):439-459. PubMed ID: 35377276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
    Wahn U; Bos JD; Goodfield M; Caputo R; Papp K; Manjra A; Dobozy A; Paul C; Molloy S; Hultsch T; Graeber M; Cherill R; de Prost Y;
    Pediatrics; 2002 Jul; 110(1 Pt 1):e2. PubMed ID: 12093983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New and Upcoming Topical Treatments for Atopic Dermatitis: A Review of the Literature.
    Sideris N; Paschou E; Bakirtzi K; Kiritsi D; Papadimitriou I; Tsentemeidou A; Sotiriou E; Vakirlis E
    J Clin Med; 2022 Aug; 11(17):. PubMed ID: 36078904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of baricitinib in combination with topical corticosteroids in patients with moderate-to-severe atopic dermatitis with inadequate response, intolerance or contraindication to ciclosporin: results from a randomized, placebo-controlled, phase III clinical trial (BREEZE-AD4).
    Bieber T; Reich K; Paul C; Tsunemi Y; Augustin M; Lacour JP; Ghislain PD; Dutronc Y; Liao R; Yang FE; Brinker D; DeLozier AM; Meskimen E; Janes JM; Eyerich K;
    Br J Dermatol; 2022 Sep; 187(3):338-352. PubMed ID: 35484697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of atopic dermatitis with KAM-3008, a barrier-based, non-steroidal topical cream.
    Bomstein Y; Rozenblat S
    J Dermatolog Treat; 2015 Oct; 26(5):426-30. PubMed ID: 25893370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitis.
    Hebert AA
    Clin Ther; 2006 Dec; 28(12):1972-82. PubMed ID: 17296454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Janus kinase inhibitors for the therapy of atopic dermatitis.
    Traidl S; Freimooser S; Werfel T
    Allergol Select; 2021; 5():293-304. PubMed ID: 34532638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of Janus kinase (JAK) inhibitors in the short-term treatment of atopic dermatitis.
    Wood H; Chandler A; Nezamololama N; Papp K; Gooderham MJ
    Int J Dermatol; 2022 Jun; 61(6):746-754. PubMed ID: 34423443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delgocitinib in atopic dermatitis.
    Ho J; Molin S
    Drugs Today (Barc); 2021 Dec; 57(12):719-731. PubMed ID: 34909801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Itch in Atopic Dermatitis - What Is New?
    Legat FJ
    Front Med (Lausanne); 2021; 8():644760. PubMed ID: 34026782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Janus kinase inhibitors for atopic dermatitis: a promising treatment modality.
    Cartron AM; Nguyen TH; Roh YS; Kwatra MM; Kwatra SG
    Clin Exp Dermatol; 2021 Jul; 46(5):820-824. PubMed ID: 33484582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical Agents Currently in Phase II or Phase III Trials for Atopic Dermatitis.
    Uppal SK; Chat VS; Kearns DG; Wu JJ
    J Drugs Dermatol; 2020 Oct; 19(10):956-959. PubMed ID: 33026767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of Short Term Topical Malva Sylvestris L. Cream in Pediatric Patients with Atopic Dermatitis: A Randomized Double-Blind Placebo-Controlled Clinical Trial.
    Meysami M; Hashempur MH; Kamalinejad M; Emtiazy M
    Endocr Metab Immune Disord Drug Targets; 2021; 21(9):1673-1678. PubMed ID: 33100212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial.
    Reich K; Teixeira HD; de Bruin-Weller M; Bieber T; Soong W; Kabashima K; Werfel T; Zeng J; Huang X; Hu X; Hendrickson BA; Ladizinski B; Chu AD; Silverberg JI
    Lancet; 2021 Jun; 397(10290):2169-2181. PubMed ID: 34023009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Off-label studies on ruxolitinib in dermatology: a review.
    Wu J; Smogorzewski J
    J Dermatolog Treat; 2022 Mar; 33(2):606-612. PubMed ID: 32515635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and Safety of Upadacitinib for Management of Moderate-to-Severe Atopic Dermatitis: An Evidence-Based Review.
    Lytvyn Y; Mufti A; Abduelmula A; Sachdeva M; Maliyar K; Georgakopoulos JR; Yeung J
    Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36432643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient acceptability, efficacy, and skin biophysiology of a cream and cleanser containing lipid complex with shea butter extract versus a ceramide product for eczema.
    Hon KL; Tsang YC; Pong NH; Lee VW; Luk NM; Chow CM; Leung TF
    Hong Kong Med J; 2015 Oct; 21(5):417-25. PubMed ID: 26314567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacodynamics of Janus kinase inhibitors for the treatment of atopic dermatitis.
    Calabrese L; Chiricozzi A; De Simone C; Fossati B; D'Amore A; Peris K
    Expert Opin Drug Metab Toxicol; 2022 May; 18(5):347-355. PubMed ID: 35796377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. JAK/STAT inhibitors for the treatment of atopic dermatitis.
    Rodrigues MA; Torres T
    J Dermatolog Treat; 2020 Feb; 31(1):33-40. PubMed ID: 30703333
    [No Abstract]   [Full Text] [Related]  

  • 40. A starch, glycyrretinic, zinc oxide and bisabolol based cream in the treatment of chronic mild-to-moderate atopic dermatitis in children: a three-center, assessor blinded trial.
    Licari A; Ruffinazzi G; DE Filippo M; Castagnoli R; Marseglia A; Agostinis F; Puviani M; Milani M; Marseglia GL
    Minerva Pediatr; 2017 Dec; 69(6):470-475. PubMed ID: 29181960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.